The Mac Is Back: The Role of Macrophages in Human Healthy and Complicated Pregnancies.

chronic histiocytic intervillositis decidua immune cell interactions macrophages oocyte donation pregnancy recurrent pregnancy loss

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Mar 2023
Historique:
received: 28 12 2022
revised: 28 02 2023
accepted: 02 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Pregnancy is a fascinating immunological paradox: the semi-allogeneic fetus generally grows without any complications. In the placenta, fetal trophoblast cells come into contact with maternal immune cells. Inaccurate or inadequate adaptations of the maternal immune system could lead to problems with the functioning of the placenta. Macrophages are important for tissue homeostasis, cleanup, and the repair of damaged tissues. This is crucial for a rapidly developing organ such as the placenta. The consensus on macrophages at the maternal-fetal interface in pregnancy is that a major proportion have an anti-inflammatory, M2-like phenotype, that expresses scavenger receptors and is involved in tissue remodeling and the dampening of the immune reactions. Recent multidimensional analyses have contributed to a more detailed outlook on macrophages. The new view is that this lineage represents a highly diverse phenotype and is more prevalent than previously thought. Spatial-temporal in situ analyses during gestation have identified unique interactions of macrophages both with trophoblasts and with T cells at different trimesters of pregnancy. Here, we elaborate on the role of macrophages during early human pregnancy and at later gestation. Their possible effect is reviewed in the context of HLA incompatibility between mother and fetus, first in naturally conceived pregnancies, but foremost in pregnancies after oocyte donation. The potential functional consequences of macrophages for pregnancy-related immune reactions and the outcome in patients with recurrent pregnancy loss are also discussed.

Identifiants

pubmed: 36982375
pii: ijms24065300
doi: 10.3390/ijms24065300
pmc: PMC10049527
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Front Immunol. 2021 Jun 07;12:689019
pubmed: 34168655
J Formos Med Assoc. 2018 Mar;117(3):204-211
pubmed: 28465068
J Reprod Immunol. 2011 Dec;92(1-2):97-102
pubmed: 22015003
J Immunol. 2013 Oct 1;191(7):3734-43
pubmed: 23997215
Am J Reprod Immunol. 2019 Jan;81(1):e13054
pubmed: 30267451
Int J Mol Sci. 2020 Jan 31;21(3):
pubmed: 32023856
J Reprod Immunol. 2014 Mar;101-102:96-103
pubmed: 24029471
Immunol Invest. 2008;37(5):535-64
pubmed: 18716937
Am J Pathol. 2009 May;174(5):1959-71
pubmed: 19349361
Nat Immunol. 2004 Mar;5(3):266-71
pubmed: 14758358
PLoS One. 2008 Apr 30;3(4):e2078
pubmed: 18446208
Cell Rep. 2023 Jan 31;42(1):111977
pubmed: 36640334
Hum Immunol. 2005 Mar;66(3):222-30
pubmed: 15784460
Front Immunol. 2017 Oct 25;8:1357
pubmed: 29123519
Nature. 2018 Nov;563(7731):347-353
pubmed: 30429548
Cell Mol Immunol. 2016 Sep;13(5):615-27
pubmed: 26027727
Curr Opin Organ Transplant. 2016 Feb;21(1):40-4
pubmed: 26575853
Ann Rheum Dis. 2004 Jul;63(7):774-84
pubmed: 15194571
J Reprod Immunol. 2013 Dec;100(2):109-17
pubmed: 24045115
Front Immunol. 2020 Jun 23;11:1182
pubmed: 32655556
J Reprod Immunol. 2010 May;85(1):40-6
pubmed: 20356631
Gynecol Endocrinol. 2019 Apr;35(4):314-319
pubmed: 30626251
Hum Immunol. 2021 May;82(5):325-331
pubmed: 33715911
Placenta. 2001 Apr;22(4):309-16
pubmed: 11286566
Am J Reprod Immunol. 2004 Apr;51(4):275-82
pubmed: 15212680
Hum Reprod. 2015 Oct;30(10):2263-74
pubmed: 26307092
Am J Obstet Gynecol. 2019 Nov;221(5):457-469
pubmed: 31288009
Am J Obstet Gynecol. 1999 Sep;181(3):718-24
pubmed: 10486489
J Immunol. 2011 Feb 15;186(4):2633-42
pubmed: 21257965
Am J Anat. 1956 May;98(3):435-93
pubmed: 13362122
FASEB J. 2012 Dec;26(12):4876-85
pubmed: 22919072
J Reprod Immunol. 2015 Nov;112:73-80
pubmed: 26340023
Reprod Biomed Online. 2020 Oct;41(4):679-685
pubmed: 32811769
Biol Reprod. 2007 Mar;76(3):448-54
pubmed: 17151353
Reprod Biomed Online. 2017 Jan;34(1):11-18
pubmed: 27793549
Front Immunol. 2014 Nov 24;5:606
pubmed: 25505471
J Leukoc Biol. 2016 Aug;100(2):315-25
pubmed: 26819320
Am J Reprod Immunol. 2010 Jun;63(6):460-71
pubmed: 20163399
Int J Mol Sci. 2012;13(7):9069-9080
pubmed: 22942752
Front Immunol. 2021 Dec 08;12:772729
pubmed: 34956198
Hum Reprod Update. 2000 Jan-Feb;6(1):28-36
pubmed: 10711827
Biol Reprod. 2005 Aug;73(2):237-43
pubmed: 15800179
Hum Reprod Open. 2018 Apr 06;2018(2):hoy004
pubmed: 31486805
J Immunol. 2015 Feb 15;194(4):1534-44
pubmed: 25560409
Hum Immunol. 2022 Apr;83(4):319-327
pubmed: 34785097
iScience. 2022 Jun 20;25(7):104648
pubmed: 35811852
J Immunol. 2017 May 15;198(10):4115-4128
pubmed: 28396316
BJOG. 2017 Mar;124(4):561-572
pubmed: 27592694
Placenta. 2017 Aug;56:44-52
pubmed: 28284455
Nat Commun. 2022 Mar 15;13(1):1252
pubmed: 35292627
Transpl Immunol. 2011 Sep;25(2-3):89-95
pubmed: 21708252
Blood. 2010 Oct 21;116(16):e74-80
pubmed: 20628149
J Reprod Immunol. 2020 Feb;137:103074
pubmed: 31864034
J Immunol. 2011 Oct 1;187(7):3671-82
pubmed: 21890660
Front Immunol. 2014 Jun 30;5:298
pubmed: 25071761
Biol Reprod. 1975 Feb;12(1):41-65
pubmed: 1095088
Placenta. 2019 Mar;78:23-28
pubmed: 30955707
Nat Med. 2020 Oct;26(10):1644-1653
pubmed: 32929266
PLoS One. 2012;7(3):e32347
pubmed: 22479322
J Reprod Immunol. 2021 Feb;143:103264
pubmed: 33360717
J Reprod Immunol. 2012 Jun;94(2):131-41
pubmed: 22542910
J Leukoc Biol. 2020 Sep;108(3):983-998
pubmed: 32386458
Am J Reprod Immunol. 2022 Jan;87(1):e13511
pubmed: 34738274
Front Immunol. 2021 May 13;12:673131
pubmed: 34054856
Front Immunol. 2021 Oct 21;12:758281
pubmed: 34745133
Front Immunol. 2018 Mar 23;9:585
pubmed: 29662491
Front Immunol. 2017 Feb 09;8:120
pubmed: 28232836
J Reprod Immunol. 2009 Nov;82(2):148-57
pubmed: 19631389
Sci Rep. 2016 Jun 17;6:28127
pubmed: 27311852
Cell Discov. 2021 Jan 4;7(1):1
pubmed: 33390590
J Reprod Immunol. 2020 Jun;139:103105
pubmed: 32199194
Development. 2019 Nov 27;146(22):
pubmed: 31776138
Clin Exp Immunol. 2003 Mar;131(3):498-505
pubmed: 12605704
Am J Reprod Immunol. 2016 Mar;75(3):298-309
pubmed: 26750089
Hum Reprod Update. 2010 Nov-Dec;16(6):704-12
pubmed: 20543201
Cell. 2012 Jul 6;150(1):29-38
pubmed: 22770213
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):385-390
pubmed: 29259116
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19446-51
pubmed: 18042719
Front Immunol. 2022 Dec 02;13:1045532
pubmed: 36532057
Cell Mol Immunol. 2018 Dec;15(12):1027-1037
pubmed: 29618777
Int J Biochem Cell Biol. 2005 Jan;37(1):1-16
pubmed: 15381142
Biol Reprod. 2003 Oct;69(4):1438-46
pubmed: 12826583
Am J Obstet Gynecol. 2016 Mar;214(3):328-39
pubmed: 26627731
J Immunol. 2012 Mar 15;188(6):2703-11
pubmed: 22327074
Front Immunol. 2020 Oct 26;11:571300
pubmed: 33193353
Am J Pathol. 2005 Mar;166(3):811-22
pubmed: 15743793
Front Immunol. 2022 May 13;13:814019
pubmed: 35634345
Eur J Obstet Gynecol Reprod Biol. 2017 Nov;218:60-67
pubmed: 28942045
J Reprod Immunol. 2002 Jul-Aug;56(1-2):3-17
pubmed: 12106880
Cell Mol Immunol. 2018 Dec;15(12):1038-1046
pubmed: 29588487

Auteurs

Juliette Krop (J)

Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Xuezi Tian (X)

Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Department of Obstetrics and Gynaecology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Marie-Louise van der Hoorn (ML)

Department of Obstetrics and Gynaecology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Michael Eikmans (M)

Department of Immunology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH